CVRx Launches Next-Generation Barostim Neo2 Implantable Pulse Generator to Treat Heart Failure Symptoms
November 14, 2022—CVRx, Inc., developer of the FDA-approved Barostim neuromodulation device to treat the symptoms of heart failure, recently ann
Source: evtoday.com